Page 49 - The lraternational Journal of the Royal Society of Thailand.indd
P. 49

The International Journal of the Royal Society of Thailand
                                                                                                Volume XV-2023



                  during the height of the first wave of the pandemic (spring 2020 to January 2021), and
                  the intervention proved to be highly efficacious (Tripura et al, 2023; Maude et al, 2021).
                  This study to assess efficacy of artemether-lumefantrine prophylaxis against forest
                  malaria in Cambodia (ClinicalTrials.gov Identifier: NCT04041973) was completed on
                  time despite initial concerns that it would need to be postponed or abandoned due to

                  COVID-19. In total, 1400 participants joined the study and treatment adherence and
                  re-enrolment rates were considerably higher than anticipated despite the challenges.


                  The Cham Bok health centre field station
                         In the context of declining malaria transmission in Cambodia due to successful

                  control measures, to increase recruitment into the EFFORT and DeTACT trials, during
                  2021 a new research station was established at Cham Bok in western Cambodia, close
                  to forested areas and national parks in which malaria transmission persists. Beginning
                  work in a new province involved developing new relationships with local partners

                  and high-level support from CNM to explain the need to continue research while
                  other activities were being closed due to the pandemic.


                  The development of triple artemisinin combination therapy trial
                         Resistance to artemisinins and partner drugs used in artemisinin combination

                  therapies is a risk to malaria control and elimination in Southeast Asia. In Cambodia
                  and elsewhere, MORU and partners have trialled triple artemisinin combination
                  therapies to address this (van der Pluijm et al, 2019; Peto et al, 2022; van der Pluijm
                  et al, 2020). A trial to compare the efficacy, safety and tolerability of combinations
                  of 3 anti-malarial drugs against combinations of 2 anti-malarial drugs (ClinicalTrials.

                  gov Identifier: NCT03939104) was scheduled to begin in 2020 but its start was delayed
                  until 2021 due to constraints on training and logistics at the remote study sites in
                  Pursat and Stung Treng. The ongoing study was able to take measures to catch up due

                  to intensive efforts and support from partners, and it is now on course to achieve
                  close to the initial target sample size of participants.


                  Kravanh research site in Pursat Province during COVID-19
                         Kravanh district is located within the Pursat province that consists of villages
                  nestling along the periphery of Kravnah mountain (part of the Cardamom mountain

                  range) with some areas tht are densely forested. Recognized as one of the major
                  endemic districts for malaria, Kravanh as a research site for MORU was established
                  in  2018  that  coincided  with  the  decline  in  malaria  in  Pailin  and  Battambang.
                  MORU’s research office was built within the confines of the Kravanh referral hospital

                  where CNM, PHD and district hospital authorities generously offered a space.



                        Dysoley Lek et al.                                                                41
   44   45   46   47   48   49   50   51   52   53   54